Steve Busch

446 total citations
10 papers, 354 citations indexed

About

Steve Busch is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Steve Busch has authored 10 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Steve Busch's work include Peptidase Inhibition and Analysis (3 papers), Immunotherapy and Immune Responses (2 papers) and Neuropeptides and Animal Physiology (2 papers). Steve Busch is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Immunotherapy and Immune Responses (2 papers) and Neuropeptides and Animal Physiology (2 papers). Steve Busch collaborates with scholars based in United States, Switzerland and Canada. Steve Busch's co-authors include Charles A. Powell, Alain Borczuk, Jerome S. Brody, William G. Richards, Charles DeLisi, Sudhir Sahasrabudhe, Adnan Derti, Raphael Bueno, David J. Sugarbaker and Gang Liu and has published in prestigious journals such as European Journal of Immunology, Molecular Therapy and Toxicological Sciences.

In The Last Decade

Steve Busch

10 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Busch United States 8 190 68 60 56 46 10 354
Shigeru Sugaya Japan 12 272 1.4× 80 1.2× 20 0.3× 65 1.2× 72 1.6× 33 403
Alexander Bank United States 7 209 1.1× 113 1.7× 30 0.5× 53 0.9× 55 1.2× 11 337
Surya Amarachintha United States 13 191 1.0× 59 0.9× 36 0.6× 21 0.4× 43 0.9× 26 358
Pengyu Jing China 11 309 1.6× 94 1.4× 59 1.0× 23 0.4× 112 2.4× 23 417
Tanner J. Freeman United States 8 238 1.3× 136 2.0× 44 0.7× 29 0.5× 95 2.1× 13 446
Xue Jun Zhang China 11 180 0.9× 90 1.3× 21 0.3× 23 0.4× 42 0.9× 22 376
Sara McNally Ireland 9 286 1.5× 166 2.4× 41 0.7× 62 1.1× 130 2.8× 14 555
Juwon Jang South Korea 12 350 1.8× 108 1.6× 40 0.7× 175 3.1× 84 1.8× 17 542
Kevin D. Houston United States 13 228 1.2× 51 0.8× 22 0.4× 48 0.9× 58 1.3× 22 418
Georgina Mancinelli United States 9 131 0.7× 155 2.3× 24 0.4× 51 0.9× 68 1.5× 13 316

Countries citing papers authored by Steve Busch

Since Specialization
Citations

This map shows the geographic impact of Steve Busch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Busch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Busch more than expected).

Fields of papers citing papers by Steve Busch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Busch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Busch. The network helps show where Steve Busch may publish in the future.

Co-authorship network of co-authors of Steve Busch

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Busch. A scholar is included among the top collaborators of Steve Busch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Busch. Steve Busch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dong, Linda M., Saar Gill, Vijay Bhoj, et al.. (2016). 399. Evaluation of CD123 Targeting CART Cells in Non-Human Primates. Molecular Therapy. 24. S158–S158. 2 indexed citations
2.
Hoffmann, Peter, et al.. (2016). Acute Toxicity of Vildagliptin. Toxicologic Pathology. 45(1). 76–83. 7 indexed citations
3.
Hoffmann, Peter, Pritam S. Sahota, Heidi A. Schoenfeld, et al.. (2014). Vascular Origin of Vildagliptin-induced Skin Effects in Cynomolgus Monkeys. Toxicologic Pathology. 42(4). 684–695. 21 indexed citations
4.
Moggs, Jonathan G., Pierre Moulin, François Pognan, et al.. (2012). Investigative safety science as a competitive advantage for Pharma. Expert Opinion on Drug Metabolism & Toxicology. 8(9). 1071–1082. 13 indexed citations
5.
McLean, Lee Anne, Chiara Buono, Pierre Moulin, et al.. (2011). The Use of Rat Lens Explant Cultures to Study the Mechanism of Drug-Induced Cataractogenesis. Toxicological Sciences. 126(1). 128–139. 6 indexed citations
6.
Alkan, Şefik Ş., Arun Subramaniam, Fan Long, et al.. (2005). Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN‐γ or IL‐4: Characterization of Th cells isolated by FACS based on IFN‐γ and IL‐4 secretion. European Journal of Immunology. 35(9). 2709–2717. 19 indexed citations
7.
Epstein, Charles B., Hong Liu, Nanxiang Ge, et al.. (2004). Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study. BMC Genomics. 5(1). 26–26. 72 indexed citations
8.
Singleton, David W., Yuxin Feng, Steve Busch, et al.. (2004). Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Molecular and Cellular Endocrinology. 221(1-2). 47–55. 33 indexed citations
9.
Powell, Charles A., Avrum Spira, Adnan Derti, et al.. (2003). Gene Expression in Lung Adenocarcinomas of Smokers and Nonsmokers. American Journal of Respiratory Cell and Molecular Biology. 29(2). 157–162. 100 indexed citations
10.
Kim, Han, Guo-Liang Xu, Alain Borczuk, et al.. (2003). The Heparan Sulfate Proteoglycan GPC3 Is a Potential Lung Tumor Suppressor. American Journal of Respiratory Cell and Molecular Biology. 29(6). 694–701. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026